This information should be interpreted with a qualified healthcare provider and used alongside clinical biomarkers (fasting glucose, lipid panel, kidney function) to inform medication choice and expected timeline for results
If insurance doesn't cover your GLP-1 medicationor if youre uninsuredyou can purchase it privately
They can, anyway
The cardiovascular system and its pathophysiology are complex and GLP-1 asserts its effects through numerous pathways
During the opening lecture at the International Conference on Advanced Technologies & Treatments for Diabetes, Melanie Davies, CBE, MB, ChB, MD, FRCP, FRCGP, professor of diabetes medicine at the University of Leicester and an honorary consultant diabetologist at the University Hospitals of Leicester NHS Trust, reviewed how GLP-1 receptor agonists such as semaglutide (Ozempic/Wegovy, Novo Nordisk) have changed the way providers approach the treatment of type 2 diabetes and obesity and discussed some of the medications that combine GLP-1 with other molecules
